Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Aug;64(8):1148-53.
doi: 10.1001/archneur.64.8.1148.

Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations

Affiliations

Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations

Vivianna M Van Deerlin et al. Arch Neurol. 2007 Aug.

Abstract

Background: Patients with frontotemporal dementia due to mutation of progranulin may have a distinct phenotype.

Objective: To identify distinct clinical and pathologic features of patients with frontotemporal dementia who have mutations of progranulin (GRN).

Design: Retrospective clinical-pathologic study.

Setting: Academic medical center.

Patients: Twenty-eight patients with frontotemporal dementia, including 9 with GRN mutations (4 autopsy cases and 5 with only clinical information) and 19 with the identical pathologic diagnosis--frontotemporal lobar degeneration with ubiquitin-positive and tau-negative inclusions (FTLD-U)--and no GRN mutations.

Main outcome measures: Demographic, symptom, neuropsychological, and autopsy characteristics.

Results: Patients with and without a GRN mutation have similar demographic features, although family history is significantly more common in patients with frontotemporal dementia and a GRN mutation. Both patient groups have frequent social and personality complaints. Neuropsychological evaluation reveals a significant recognition memory deficit in patients with a GRN mutation but a significant language deficit only in patients without a GRN mutation. At autopsy, the semiquantitative burden of ubiquitin abnormality is relatively modest in both groups of patients.

Conclusion: Patients with a GRN mutation differ clinically from those with the same pathologic diagnosis but no GRN mutation.

PubMed Disclaimer

Similar articles

Cited by

  • ABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target.
    Nelson PT, Jicha GA, Wang WX, Ighodaro E, Artiushin S, Nichols CG, Fardo DW. Nelson PT, et al. Ageing Res Rev. 2015 Nov;24(Pt B):111-25. doi: 10.1016/j.arr.2015.07.007. Epub 2015 Jul 28. Ageing Res Rev. 2015. PMID: 26226329 Free PMC article. Review.
  • Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
    Cruchaga C, Haller G, Chakraverty S, Mayo K, Vallania FL, Mitra RD, Faber K, Williamson J, Bird T, Diaz-Arrastia R, Foroud TM, Boeve BF, Graff-Radford NR, St Jean P, Lawson M, Ehm MG, Mayeux R, Goate AM; NIA-LOAD/NCRAD Family Study Consortium. Cruchaga C, et al. PLoS One. 2012;7(2):e31039. doi: 10.1371/journal.pone.0031039. Epub 2012 Feb 1. PLoS One. 2012. PMID: 22312439 Free PMC article.
  • "New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS).
    Nelson PT, Trojanowski JQ, Abner EL, Al-Janabi OM, Jicha GA, Schmitt FA, Smith CD, Fardo DW, Wang WX, Kryscio RJ, Neltner JH, Kukull WA, Cykowski MD, Van Eldik LJ, Ighodaro ET. Nelson PT, et al. J Neuropathol Exp Neurol. 2016 Jun;75(6):482-98. doi: 10.1093/jnen/nlw033. Epub 2016 May 21. J Neuropathol Exp Neurol. 2016. PMID: 27209644 Free PMC article. Review.
  • Update on frontotemporal dementia.
    Arvanitakis Z. Arvanitakis Z. Neurologist. 2010 Jan;16(1):16-22. doi: 10.1097/NRL.0b013e3181b1d5c6. Neurologist. 2010. PMID: 20065792 Free PMC article. Review.
  • Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study.
    Poos JM, Russell LL, Peakman G, Bocchetta M, Greaves CV, Jiskoot LC, van der Ende EL, Seelaar H, Papma JM, van den Berg E, Pijnenburg YAL, Borroni B, Sanchez-Valle R, Moreno F, Laforce R, Graff C, Synofzik M, Galimberti D, Rowe JB, Masellis M, Tartaglia C, Finger E, Vandenberghe R, de Medonça A, Tagliavini F, Butler CR, Santana I, Ber IL, Gerhard A, Ducharme S, Levin J, Danek A, Otto M, Sorbi S, Pasquier F, van Swieten JC, Rohrer JD; Genetic FTD Initiative, GENF. Poos JM, et al. Alzheimers Dement (Amst). 2021 May 13;13(1):e12185. doi: 10.1002/dad2.12185. eCollection 2021. Alzheimers Dement (Amst). 2021. PMID: 34027016 Free PMC article.

Publication types

MeSH terms